PMC:7243768 / 67815-67940
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2641 | 16-28 | Species | denotes | participants | Tax:9606 |
| 2642 | 62-74 | Species | denotes | participants | Tax:9606 |
| 2647 | 38-48 | Chemical | denotes | remdesivir | MESH:C000606551 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T84794 | 38-48 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
| T90328 | 49-54 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T97276 | 92-97 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T501 | 0-125 | Sentence | denotes | One hundred two participants from the remdesivir group and 50 participants from the placebo group exhibited adverse outcomes. |